<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">56319</article-id><article-id pub-id-type="doi">10.7554/eLife.56319</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-178983"><name><surname>Keefe</surname><given-names>Matthew D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178984"><name><surname>Soderholm</surname><given-names>Haille E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178985"><name><surname>Shih</surname><given-names>Hung-Yu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178986"><name><surname>Stevenson</surname><given-names>Tamara J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178987"><name><surname>Glaittli</surname><given-names>Kathryn A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178988"><name><surname>Bowles</surname><given-names>D Miranda</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178989"><name><surname>Scholl</surname><given-names>Erika</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178990"><name><surname>Colby</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178991"><name><surname>Merchant</surname><given-names>Samer</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-178992"><name><surname>Hsu</surname><given-names>Edward W</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-100214"><name><surname>Bonkowsky</surname><given-names>Joshua L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8775-147X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><institution content-type="dept">Pediatrics</institution>, <institution>University of Utah</institution>, <addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Bioengineering</institution>, <institution>University of Utah</institution>, <addr-line><named-content content-type="city">Salt Lake City</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-11670"><name><surname>Stevens</surname><given-names>Beth</given-names></name><role>Reviewing editor</role><aff><institution>Boston Children's Hospital</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>joshua.bonkowsky@hsc.utah.edu</email> (JB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>12</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e56319</elocation-id><history><date date-type="received"><day>24</day><month>02</month><year>2020</year></date><date date-type="accepted"><day>09</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Keefe et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Keefe et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-56319-v1.pdf"/><abstract><p>Vanishing White Matter disease (VWM) is a severe leukodystrophy of the central nervous system caused by mutations in subunits of the eukaryotic initiation factor 2B complex (eIF2B). Current models only partially recapitulate key disease features, and pathophysiology is poorly understood. Through development and validation of zebrafish (<italic>Danio rerio</italic>) models of VWM, we demonstrate that zebrafish <italic>eif2b </italic>mutants phenocopy VWM, including impaired somatic growth, early lethality, effects on myelination, loss of oligodendrocyte precursor cells, increased apoptosis in the CNS, and impaired motor swimming behavior. Expression of human <italic>EIF2B2</italic> in the zebrafish <italic>eif2b2</italic> mutant rescues lethality and CNS apoptosis, demonstrating conservation of function between zebrafish and human. In the mutants, intron 12 retention leads to expression of a truncated <italic>eif2b5</italic> transcript. Expression of the truncated <italic>eif2b5</italic> in wild-type larva impairs motor behavior and activates the ISR, suggesting that a feed-forward mechanism in VWM is a significant component of disease pathophysiology.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>1R21 NS109441-01</award-id><principal-award-recipient><name><surname>Bonkowsky</surname><given-names>Joshua L</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007747</institution-id><institution>University of Utah</institution></institution-wrap></funding-source><award-id>Bray Chair</award-id><principal-award-recipient><name><surname>Bonkowsky</surname><given-names>Joshua L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Joshua L Bonkowsky, Consultant:Bluebird Bio (5/2017; 10/2017; 11/2019)Calico (1/2018-1/2019)Denali therapeutics (6/2019)Enzyvant (6/2019)Neurogene (3/2020)Board of Directorswfluidx 1/2018-presentStockOrchard Therapeutics.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Zebrafish experiments were performed in strict accordance of guidelines from the University of Utah Institutional Animal Care and Use Committee (IACUC), regulated under federal law (the Animal Welfare Act and Public Health Services Regulation Act) by the U.S. Department of Agriculture (USDA) and the Office of Laboratory Animal Welfare at the NIH, and accredited by the Association for Assessment and Accreditation of Laboratory Care International (AAALAC).</p></fn><fn fn-type="other"><p>Human subjects: Human subjects-related aspects of the study were approved by the Institutional Review Board of the University of Utah and the Privacy Board of Intermountain Healthcare.  Informed consent was obtained including consent to publish, protocol #19596.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1,  2, 3, 4, 5, and 6.</p></sec><supplementary-material><ext-link xlink:href="elife-56319-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>